Naval Daver, M.D.

@Daver_Leukemia

Interests: #AML , #MDS, #Immunotherapy, #FLT3, #TP53 . Faculty at @LeukemiaMDA. Clinical research, education. Dad of three. Tweets are mine.

Houston, TX faculty.mdanderson.org/Naval_Daver/De… Joined December 2014

6.6K Following 6.5K Followers 2.6K Posts

Latest posts 5

Naval Daver, M.D. @Daver_Leukemia Aug 19

Congratulations Sankalp - outstanding review. Captures cutting edge changes and progress in FLT3m AML - probably the leukemia molecular subset with the most dynamic progress in the last decade @garciamanero @sanamloghavi @jaltmanmd @EuniceWangMD @NicholasShortMD @charliecraddock

Sankalp Arora, MD @sankalparoraMD Aug 19

Out in @tandfonline Expert Review of Hematology: our review on treatment of older adults with FLT3 mut AML, with focus on practical considerations of using HMA+VEN+FLT3i triplets.

tandfonline.com/eprint/HQG8EUT…

@Daver_Leukemia @NicholasShortMD @huntsmancancer @UTMDAnderson

#leusm

View quoted post on X

Naval Daver, M.D. @Daver_Leukemia Aug 15

This is a fantastic and probably one of the best constellation of cutting edge reviews of Hemepath , with clinical translation of molecular advancements! Truly a tour de force. Congratulations @sanamloghavi @ljmedeirosMD! @UTMDAnderson @charliecraddock @ppisters @garciamanero

Sanam Loghavi, MD صنم لغوی 🔬🧬 Verified account @sanamloghavi Aug 15

Excited and proud to share our special issue on #Leukemia that @ljmedeirosMD & I put together for @Human_Pathology We brought together incredible experts to write about the latest in the field.
13 articles, each one #hemepath GOLD💎! 1/14🧵
Starting with our intro to the issue sciencedirect.com/science/articl…

View quoted post on X

Naval Daver, M.D. @Daver_Leukemia Jul 26

Tremendous meeting/discussions and huge thanks for the invitation @jaltmanmd @jmikhaelmd @JohnPLeonardMD . Also got to hear one of the best talks and overviews of MPN from @doctorpemm !

Naveen Pemmaraju, MD @doctorpemm Jul 26

👉👉👉Fantastic meeting #LLMGreatDebates @llmcongress ! Thanks 🙏 for invitation @jaltmanmd @jmikhaelmd @JohnPLeonardMD | Grateful to be invited to speak on “Personalizing Care Across The MPN Spectrum” covering state-of-the-art updates in ET, PV, and MF #MPNSM @yasminabaza1

View quoted post on X

Naval Daver, M.D. @Daver_Leukemia Jun 18

Thank you @doctorpemm . A tremendous effort by @sankalparoraMD to publish prospective study of AZA+Ruxo with 10+ year follow up. Importantly showing safety/efficacy of this regimen for this rare disease subset. @beatalleukemia @Ramikomrokji @MrinalPatnaik @GMontalbanBravo

Naveen Pemmaraju, MD @doctorpemm Jun 18

👉👉👉Delighted to share our group’s brand new paper 📝 just out in Journal of Hematology&Oncology! Final Ph2 clinical trial results RUXO+AZA in patients with MPN/MDS Led by Dr .@sankalparoraMD & Dr .@Daver_Leukemia | #MPNSM #leusm || @sanamloghavi

link.springer.com/article/10.118…

View quoted post on X

Naval Daver, M.D. @Daver_Leukemia Jun 16

Wonderful to celebrate with tremendous group of friends and warriors against leukemias! Congratulations Naveen and our international community for the collaboration and this breakthrough success! @LeukDocJZ @lane_andy @sanamloghavi @beatalleukemia @TapKadia @AkEisfeld

Naveen Pemmaraju, MD @doctorpemm Jun 16

#EHA26 #EHA2026 Final evening thanks to @_MDEducation @Ryan_Fitzpatric for a lovely educational event featuring #BPDCN #MPNSM #leusm & 🙏 all of my colleagues who helped celebrate our recent breakthroughs #BPDCN together! Such A great #community❤️ ! @beatalleukemia @sanamloghavi

View quoted post on X